- In January 2025, Thermo Fisher Scientific announced the launch of its new Ion Proton system for next-generation sequencing (NGS), aimed at enhancing single-cell RNA sequencing applications. The system is designed to improve throughput, accuracy, and reduce costs for single-cell analysis, enabling better insights into gene expression and cellular heterogeneity in cancer, immunology, and neuroscience
- In December 2024, BD (Becton, Dickinson and Company) unveiled its latest BD FACSCellQuest Pro software for single-cell analysis, which integrates enhanced data analysis tools, improving the precision of flow cytometry. The software allows researchers to gain deeper insights into immune system disorders and cancer, making it easier to detect rare cell populations
- In November 2024, 10x Genomics launched its Chromium X platform, a breakthrough in single-cell sequencing technology. The platform offers increased throughput and scalability, enabling high-quality, high-throughput gene expression analysis at the single-cell level. It is expected to be pivotal in accelerating breakthroughs in oncology and immunotherapy
- In October 2024, QIAGEN N.V. announced the launch of its new Single Cell RNA-Seq Kit, designed for high-resolution transcriptome analysis. This kit allows researchers to explore gene expression patterns at a single-cell level, helping to advance discoveries in personalized medicine, regenerative medicine, and cancer research
